Mayabeque, Cuba: A phase II-IIII clinical trial to evaluate the effect of Biomodulin T as a complementary therapy to antiretroviral treatment in patients with HIV began today in the 11 municipalities of this province.
"We have the project of new clinical indications of Biomodulina T", informed the Head of the Department of Clinical Trials, Dr. Mary Carmen Reyes Zamora.
The specialists of the National Center of Biopreparations, located in the municipality of Bejucal, are participating in this scientific project.
Compartir / Share
